
![BD HorizonTM BV786 Mouse Anti-Mouse H-2K[b]/SIINFEKL](https://biomall.ai/api/proxy-image?url=https%3A%2F%2Fwww.bdbiosciences.com%2Fcontent%2Fdam%2Fbdb%2Fproduct_assets%2Fproduct_image%2Fsingcolorpureantibody%2Fbv786%2Fimage_0%2F570015_570096-2a.png%3Fimwidth%3D320)
570096 · 25 ug
BDB Bioscience · Cat: 570096
Reach 3+ verified distributors
Manufacturer product page
bdbiosciences.com/en-us/products/reagents/flow-cytometry-rea...Description
Flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with or without prior SIINFEKL peptide treatment. Mouse splenic leukocytes were either not pulsed Left Plot or were pulsed Right Plot with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; dashed line histograms or with BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; solid line histograms at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing H-2K b /SIINFEKL expression or Ig Isotype control expression was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Multiparameter flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with prior SIINFEKL peptide treatment. Mouse splenic leukocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; Left Plot or BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2K b /SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative splenic leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with or without prior SIINFEKL peptide treatment. Mouse splenic leukocytes were either not pulsed Left Plot or were pulsed Right Plot with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; dashed line histograms or with BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; solid line histograms at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing H-2K b /SIINFEKL expression or Ig Isotype control expression was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Show More Multiparameter flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with prior SIINFEKL peptide treatment. Mouse splenic leukocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; Left Plot or BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2K b /SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative splenic leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with or without prior SIINFEKL peptide treatment. Mouse splenic leukocytes were either not pulsed Left Plot or were pulsed Right Plot with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; dashed line histograms or with BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; solid line histograms at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing H-2K b /SIINFEKL expression or Ig Isotype control expression was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Multiparameter flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with prior SIINFEKL peptide treatment. Mouse splenic leukocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; Left Plot or BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2K b /SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative splenic leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific.